Carregant...
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Despite great success in cancer immunotherapy, immune checkpoint-targeting drugs are not the most popular weapon in the armory of cancer therapy. Accumulating evidence suggests that the tumor immune microenvironment plays a critical role in anti-cancer immunity, which may result in immune checkpoint...
Guardat en:
| Publicat a: | Signal Transduct Target Ther |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7896069/ https://ncbi.nlm.nih.gov/pubmed/33608497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-020-00449-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|